Results of Randomized Double Blind Phase III trial of FDC of Remogliflozin Etabonate and Teneligliptin in T2DM patients
Keyword(s):
2003 ◽
Vol 95
(10)
◽
pp. 762-763
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 25
(8)
◽
pp. 2424-2432
◽